Similar articles

• A risk score to predict bleeding in patients with acute coronary syndromes.

  Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW. Mehran R, et al. J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66. doi: 10.1016/j.jacc.2009.09.076. J Am Coll Cardiol. 2010. PMID: 20513595 Clinical Trial.
• Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.

  Rubboli A, Halperin JL. Rubboli A, et al. Thromb Haemost. 2008 Nov;100(5):752-3. Thromb Haemost. 2008. PMID: 18989515 No abstract available.
• Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.

  Roldán V, Marín F. Roldán V, et al. Thromb Haemost. 2008 Nov;100(5):754-5. Thromb Haemost. 2008. PMID: 18989516 No abstract available.
• Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.

  Nikolsky E, Mehran R, Stone GW. Nikolsky E, et al. Am J Cardiol. 2009 Sep 7;104(5 Suppl):22C-9C. doi: 10.1016/j.amjcard.2009.06.022. Am J Cardiol. 2009. PMID: 19695357 Review.
• Antiplatelet intervention in acute coronary syndrome.

  Arora RR, Rai F. Arora RR, et al. Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238. Am J Ther. 2009. PMID: 19092648 Review.